Panelists discuss how managing advanced polycythemia vera requires tailored approaches beyond hydroxyurea when patients show resistance (persistent hematocrit >45%, elevated white blood cell counts, ...

Panelists discuss how polycythemia vera treatment follows a risk-stratified approach, with all patients receiving daily aspirin and phlebotomies to maintain hematocrit below 45%, while high-risk ...

Published Research Demonstrates the Value of BVA in Meeting Key Goal of Identifying Anemia in Heart Failure Patients Oak ...

Q1 2025 Earnings Call Transcript May 13, 2025 Operator: Good day, everyone, and welcome to Nuwellis First Quarter 2025 Earnings Conference Call. At this time, all participants are in a listen-only ...

Join Parachute implementing Terumo Blood and Cell Technologies’ Rika Plasma Donation System to enhance donor experience and help expand access to lifesaving therapies Lakewood, Colorado, May 12, 2025 ...

Poster presentations across all programs, including data from HELIOS long-term extension trial of bitopertin in ...

Good day, everyone, and welcome to Nuwellis first quarter 2025 earnings conference call. (Operator Instructions) Please note, this call is being recorded, and I will be standing by should you need any ...